Scatec ASA
Scatec ASA - Buy-back of bonds and exercise of call option
Scatec ASA - Buy-back of bonds and exercise of call option
Oslo, 6 February 2025: Reference is made to the stock exchange notice 5 February 2025 regarding Scatec ASA's issuance of new green bonds.
In conjunction with the bond issue, Scatec has bought back EUR 9.1 million of outstanding bonds with ticker “SCATC03 ESG” (ISIN NO0010931181), which will be cancelled subsequently. Scatec will call the remaining SCATC03 bonds on 20 February 2025. Please see the attached notice from Nordic Trustee AS for further information about the call option.
DNB Markets, Nordea and SpareBank 1 Markets acted as Joint Lead Managers for the transaction.
For further information, please contact: Andreas Austrell, VP IR, tel: +47 974 38 686
About Scatec ASA:
Scatec is a leading renewable energy solutions provider, accelerating access to reliable and affordable clean energy emerging markets. As a long-term player, we develop, build, own, and operate renewable energy plants, with 5 GW in operation and under construction across five continents today. We are committed to grow our renewable energy capacity, delivered by our passionate employees and partners who are driven by a common vision of 'Improving our Future'. Scatec is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'SCATC'. To learn more, visit www.scatec.com or connect with us on LinkedIn
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Zealand Pharma18.7.2025 18:30:00 CEST | Press release
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
SpringWorks Therapeutics, Inc.18.7.2025 17:30:40 CEST | Press release
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
Photocat A/S18.7.2025 17:00:00 CEST | Press release
PHOTOCAT has today applied for a transfer of its trading venue from Nasdaq First North Growth Market to Spotlight Stock Market.
Golden Ocean Group Limited18.7.2025 16:30:00 CEST | Press release
GOGL – Notice of Special General Meeting
Kapitalforeningen SDG Invest18.7.2025 16:06:31 CEST | Pressemeddelelse
Kapitalforeningen SDG Invest - Opdateret prospekt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom